| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $882.9M | — | +16.3% |
| Cost of Revenue | $220.9M | — | +27.1% |
| Gross Profit | $662.0M | — | +13.1% |
| R&D Expense | $208.3M | — | +13.2% |
| SG&A Expense | $69.5M | — | +0.9% |
| Operating Income | $273.1M | — | +16.8% |
| Pre-tax Income | $347.5M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.90B | +33.4% | -3.5% |
| Accounts Receivable | $568.0M | -54.9% | +15.3% |
| Current Assets | $8.06B | +0.8% | +20.2% |
| Total Assets | $9.13B | +1.7% | +17.6% |
| Current Liabilities | $1.70B | +4.0% | +16.8% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.13B | — | +28.5% |
| Investing Cash Flow | -$388.7M | — | -646.0% |
| Financing Cash Flow | -$262.5M | — | -1388.2% |
| +16.3% |
| Income Tax | $86.6M | — | +22.6% |
| Net Income | $260.9M | — | +14.4% |
| EPS (Basic) | $1.60 | — | +14.3% |
| EPS (Diluted) | $1.57 | — | +14.6% |
| $1.83B |
| +3.4% |
| +17.5% |
| Stockholders' Equity | $7.30B | +1.2% | +17.6% |